Success Metrics

Active Trials
3(43%)

Phase Distribution

Ph phase_1
1
14%
Ph phase_2
2
29%
Ph phase_3
3
43%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Other(4)

Detailed Status

unknown4
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 33 (50.0%)

Trials by Status

active_not_recruiting114%
unknown457%
recruiting229%

Recent Activity

3 active trials
Showing 5 of 7
recruitingphase_2

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

NCT05272696
recruitingphase_3

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

NCT06427447
active_not_recruitingphase_1

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

NCT05667298
unknown

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

NCT04737551
unknownphase_3

Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

NCT02371304
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05272696Phase 2

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

Recruiting
NCT06427447Phase 3

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Recruiting
NCT05667298Phase 1

Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer

Active Not Recruiting
NCT04737551

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Unknown
NCT02371304Phase 3

Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

Unknown
NCT03973008Phase 3

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Unknown
NCT01463501Phase 2

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Unknown

All 7 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
7